Spironolactone Ceva

RSS

Withdrawn

This medicine's authorisation has been withdrawn

spironolactone
MedicineVeterinaryWithdrawn

Czech is available via eTranslation, the European Commission's machine translation service.

Translate to Czech | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for this product has been withdrawn due to the application of the sunset clause.

български (BG) (332.91 KB - PDF)

Zobrazit

español (ES) (288.28 KB - PDF)

Zobrazit

čeština (CS) (322.23 KB - PDF)

Zobrazit

dansk (DA) (287.53 KB - PDF)

Zobrazit

Deutsch (DE) (289.53 KB - PDF)

Zobrazit

eesti (ET) (276.29 KB - PDF)

Zobrazit

ελληνικά (EL) (335.21 KB - PDF)

Zobrazit

français (FR) (289.25 KB - PDF)

Zobrazit

hrvatski (HR) (307.68 KB - PDF)

Zobrazit

latviešu (LV) (334.28 KB - PDF)

Zobrazit

Malti (MT) (324.47 KB - PDF)

Zobrazit

Nederlands (NL) (287.82 KB - PDF)

Zobrazit

polski (PL) (380.69 KB - PDF)

Zobrazit

português (PT) (288.12 KB - PDF)

Zobrazit

română (RO) (482.45 KB - PDF)

Zobrazit

slovenčina (SK) (324.97 KB - PDF)

Zobrazit

slovenščina (SL) (318.42 KB - PDF)

Zobrazit

suomi (FI) (285.73 KB - PDF)

Zobrazit

svenska (SV) (287.15 KB - PDF)

Zobrazit

Product information

български (BG) (936.84 KB - PDF)

Zobrazit

español (ES) (457.64 KB - PDF)

Zobrazit

čeština (CS) (695.23 KB - PDF)

Zobrazit

dansk (DA) (443.55 KB - PDF)

Zobrazit

Deutsch (DE) (456.17 KB - PDF)

Zobrazit

eesti (ET) (460.88 KB - PDF)

Zobrazit

ελληνικά (EL) (957.24 KB - PDF)

Zobrazit

français (FR) (383.63 KB - PDF)

Zobrazit

hrvatski (HR) (504.46 KB - PDF)

Zobrazit

italiano (IT) (614.01 KB - PDF)

Zobrazit

latviešu (LV) (750.12 KB - PDF)

Zobrazit

lietuvių (LT) (673.01 KB - PDF)

Zobrazit

magyar (HU) (1.07 MB - PDF)

Zobrazit

Malti (MT) (774.79 KB - PDF)

Zobrazit

Nederlands (NL) (445.92 KB - PDF)

Zobrazit

polski (PL) (1.09 MB - PDF)

Zobrazit

português (PT) (456.69 KB - PDF)

Zobrazit

română (RO) (807.04 KB - PDF)

Zobrazit

slovenčina (SK) (711.68 KB - PDF)

Zobrazit

slovenščina (SL) (702.28 KB - PDF)

Zobrazit

suomi (FI) (456.54 KB - PDF)

Zobrazit

svenska (SV) (441.7 KB - PDF)

Zobrazit

Íslenska (IS) (622.5 KB - PDF)

Zobrazit

norsk (NO) (656.3 KB - PDF)

Zobrazit
Latest procedure affecting product information:IAIN/0014
31/10/2012

български (BG) (299.51 KB - PDF)

Zobrazit

español (ES) (219.22 KB - PDF)

Zobrazit

čeština (CS) (262.67 KB - PDF)

Zobrazit

dansk (DA) (227.42 KB - PDF)

Zobrazit

Deutsch (DE) (218.75 KB - PDF)

Zobrazit

eesti (ET) (221.16 KB - PDF)

Zobrazit

ελληνικά (EL) (268.37 KB - PDF)

Zobrazit

français (FR) (221.14 KB - PDF)

Zobrazit

hrvatski (HR) (227.55 KB - PDF)

Zobrazit

italiano (IT) (191.92 KB - PDF)

Zobrazit

latviešu (LV) (256.74 KB - PDF)

Zobrazit

lietuvių (LT) (210.34 KB - PDF)

Zobrazit

magyar (HU) (210.45 KB - PDF)

Zobrazit

Malti (MT) (250.85 KB - PDF)

Zobrazit

Nederlands (NL) (228.06 KB - PDF)

Zobrazit

polski (PL) (245.92 KB - PDF)

Zobrazit

português (PT) (231.37 KB - PDF)

Zobrazit

română (RO) (434.62 KB - PDF)

Zobrazit

slovenčina (SK) (253.67 KB - PDF)

Zobrazit

slovenščina (SL) (237.31 KB - PDF)

Zobrazit

suomi (FI) (204.11 KB - PDF)

Zobrazit

svenska (SV) (218.51 KB - PDF)

Zobrazit

Íslenska (IS) (185.95 KB - PDF)

Zobrazit

norsk (NO) (222.67 KB - PDF)

Zobrazit

Product details

Name of medicine
Spironolactone Ceva
Active substance
spironolactone
International non-proprietary name (INN) or common name
spironolactone
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) code
QC03DA01

Pharmacotherapeutic group

Diuretics

Therapeutic indication

For use in combination with standard therapy (including diuretic support, where necessary) for the treatment of congestive heart failure caused by valvular regurgitation in dogs.

Authorisation details

EMA product number
EMEA/V/C/000105
Marketing authorisation holder
Ceva Santé Animale

10 avenue de la Ballastière
33500 Libourne
France

Opinion adopted
17/04/2007
Marketing authorisation issued
20/06/2007
Revision
7

Assessment history

This page was last updated on

Share this page